Refine
Has Fulltext
- yes (104)
Year of publication
Document Type
- Postprint (104) (remove)
Language
- English (104) (remove)
Keywords
- inflammation (6)
- LC-MS/MS (5)
- oxidative stress (5)
- α-amylase/trypsin inhibitors (5)
- cancer (4)
- insulin (4)
- obesity (4)
- sphingolipids (4)
- acid sphingomyelinase (3)
- carotenoids (3)
- disease (3)
- zinc (3)
- C-reactive protein (2)
- FGF21 (2)
- Glucagon (2)
- Inflammation (2)
- Insulin resistance (2)
- LC–MS/MS (2)
- NASH (2)
- SDS PAGE (2)
- SDS-PAGE (2)
- Solanaceae (2)
- acid ceramidase (2)
- activation (2)
- adipogenesis (2)
- adipose tissue (2)
- age (2)
- cell-based assay (2)
- cells (2)
- ceramide (2)
- cholesterol (2)
- coffee by-products (2)
- copper (2)
- cytokines (2)
- database (2)
- diet (2)
- genes (2)
- glucose (2)
- homeostasis (2)
- insulin resistance (2)
- kidney transplantation (2)
- mass spectrometry (2)
- metabolic syndrome (2)
- neurodegeneration (2)
- plasma (2)
- polyphenols (2)
- retinol (2)
- retinol-binding protein 4 (2)
- sphingosine-1-phosphate (2)
- tocopherols (2)
- wheat (2)
- 1-aminodecylidene bis-phosphonic acid (1)
- 20S proteasome (1)
- Adipose tissue (1)
- African indigenous vegetables (1)
- Akt pathway (1)
- Allantoin (1)
- Anaphylatoxin (1)
- Anatomy (1)
- Anemia (1)
- Animal (1)
- Arabica coffee (1)
- Arabica coffee beans (1)
- BMI change (1)
- Biochemical analysis (1)
- Biomarker (1)
- Blood (1)
- BoNT (1)
- BoNT/B uptake (1)
- Botulinum neurotoxin (1)
- C. elegans (1)
- COVID 19 (1)
- CRISPR editing validation (1)
- Caco-2/HT-29-MTX-model (1)
- Caenorhabitis elegans (1)
- Catecholamine (1)
- Cattle (1)
- Chrysopidae (1)
- Colorectal cancer (1)
- Colorectal carcinomas (1)
- Complement system (1)
- Confluence (1)
- Cow-side assay (1)
- DNA damage (1)
- DNA damage response (1)
- Doehlert design (1)
- Donors (1)
- Drug delivery (1)
- E-2 (1)
- Epigenetics (1)
- Europe (1)
- Experimental study (1)
- Exploration (1)
- Farber disease (1)
- Ferritin (1)
- GCN2 (1)
- GPx activity (1)
- Gestational diabetes (1)
- Global DNA methylation (1)
- Glucose homeostasis (1)
- Grave’s orbitopathy (1)
- Hemoglobin (1)
- Hepatic artery (1)
- Hepatic glucose balance (1)
- Hepatic hemodynamics (1)
- Hepatic lactate balance (1)
- Hepatic nerve (1)
- Hepatocyte (rat) (1)
- Heterocyclic aromatic amines (1)
- Hypermethylation (1)
- Iron deficiency anemia (1)
- IκB (1)
- Jurkat cells (1)
- K-RAS (1)
- LC-MRM-MS (1)
- LC/HRMS (1)
- Lymphocytes (1)
- M1/M2 differentiation (1)
- MALDI-TOF-MS (1)
- MALDI-TOF/MS (1)
- Manganese (1)
- Mendelian randomization (1)
- Method comparison (1)
- Microsatellite instability (1)
- Mitochondria (1)
- Molecular cloning and expression (1)
- NAFLD (1)
- NAFLD/MAFLD (1)
- NF-κB (1)
- Neutrophils (1)
- Nrf2 (1)
- Obesity (1)
- Oncogenes (1)
- PTH (1)
- PUFA (1)
- Perfusion (1)
- Phosphoenolpyruvate carboxykinase (1)
- Placenta (1)
- Plackett–Burman design (1)
- Portal vein (1)
- Prostaglandin E₂ (1)
- Prostaglandin receptor (1)
- Prunus avium L. (1)
- RRR (1)
- Rat (1)
- Reticulocytes (1)
- S-XRF (1)
- SCFA (1)
- SIMS techniques (1)
- Se (1)
- Smpd1 (1)
- Stress response (1)
- TEM (1)
- TLR signaling (1)
- Technique (1)
- Tenebrio molitor larvae (1)
- Tumour suppressor genes (1)
- Twister TM (1)
- Urate (1)
- VGCC (1)
- Vitamin A (1)
- Zinypr-1 (1)
- absorption (1)
- accumulation (1)
- activated carbon (1)
- adenylate-cyclase (1)
- adiponectin (1)
- adipose tissue dysregulation (1)
- adiposity (1)
- advanced glycation endproducts (1)
- aflatoxin B1 (1)
- ageing (1)
- aggregated immunoglobulin-g (1)
- aging (1)
- all-cause mortality (1)
- amitriptyline (1)
- anthropometric measures (1)
- anti-genotoxicity (1)
- anti-inflammatory nutrition (1)
- anti-inflammatory therapy (1)
- anti-oxidant activity (1)
- anti-oxidative capacity (1)
- antioxidants (1)
- anxiety-like behavior (1)
- arachidonic-acid (1)
- ascorbate (1)
- base excision repair (incision activity) (1)
- batch process (1)
- bile acids (1)
- binding (1)
- biofortification (1)
- biological pest control (1)
- biomarker (1)
- birth weight (1)
- bisphosphonates (1)
- body weight gain (1)
- botulinum toxin (1)
- bound phenolic compounds (1)
- brain (1)
- brain insulin signaling (1)
- breast cancer (1)
- c. elegans (1)
- calcination (1)
- cancer cachexia (1)
- cancer chemoprevention (1)
- cancer epidemiology (1)
- cardiovascular disease (1)
- carotenoid (1)
- carotenoid biosynthesis (1)
- cell-based in vitro assay (1)
- cellular bioimaging (1)
- cerami-des (1)
- ceramides (1)
- cereal meals (1)
- chaperones (1)
- chronic diseases (1)
- chronic fatigue (1)
- chronic psychosocial stress (1)
- chronic renal failure (1)
- chronic renal failure in children (1)
- chronic subordinate colony housing (CSC) (1)
- circadian clock (1)
- coenzyme-a (1)
- coffee processing (1)
- colorectal cancer (1)
- complement (1)
- continuous process (1)
- copper-related disorders (1)
- copy number analyses (1)
- coronary heart disease (1)
- cortisol (1)
- cysteine alkylation (1)
- depressive-like behavior (1)
- design of experiment (1)
- diabetes (1)
- dietary restriction (1)
- digestive enzymes quantification (1)
- dogs (1)
- dormancy (1)
- drug delivery (1)
- eicosanoids (1)
- electrochemistry (1)
- elevated plus-maze (1)
- endurance exercise (1)
- energy harvest (1)
- energy-metabolism (1)
- enzymology (1)
- epidemiology (1)
- equine (1)
- erythropoiesis (1)
- etanercept (1)
- exposome (1)
- exposome‐ wide association study (1)
- expression (1)
- extraction (1)
- fatigue reduction diet (1)
- fatty acid metabolism (1)
- feeding (1)
- fetal origins hypothesis (1)
- fibrosis (1)
- flavonoid (1)
- flow (1)
- flower buds (1)
- fluorescent probe (1)
- food frequency questionnaire (1)
- force-field (1)
- forebrain (1)
- fractionation (1)
- free zinc (1)
- fruit (1)
- functional inhibitors of acid sphin-gomyelinase (1)
- gallbladder cancer (1)
- gene (1)
- genetically modified BoNT (1)
- glomerular filtration rate (1)
- glucagon (1)
- glucocorticoid receptor (1)
- glucose intolerance (1)
- glutathione (1)
- glycation (1)
- goblet cells (1)
- growth (1)
- growth behavior (1)
- growth restriction (1)
- gwas (1)
- hallervorden-spatz-syndrome (1)
- health (1)
- heart (1)
- heat shock proteins (1)
- heme (1)
- hemodialysis (1)
- high-sodium (1)
- homologous recombination deficiency (1)
- homology-directed repair (1)
- hsp-70 (1)
- human excised skin (1)
- hydrolysis (1)
- immunology (1)
- in vitro blood-brain barrier model (1)
- in vitro intestinal model (1)
- increases (1)
- induced pluripotent stem cells (1)
- induction (1)
- infection (1)
- inorganic mercury (1)
- insulin signaling (1)
- insulin-resistance (1)
- insulinresistance (1)
- intercellular communication (1)
- interleukin-8 (1)
- intestinal microbiota (1)
- intestinal mucins (1)
- intestinal zinc resorption (1)
- ion-exchange chromatography (1)
- iron (1)
- keratinocytes (1)
- kupffer cells (1)
- lactate output (1)
- laminitis (1)
- later health (1)
- legumes (1)
- life-span (1)
- lifestyle (1)
- lipid metabolism (1)
- lipid peroxidation (1)
- liver (1)
- liver fibrosis (1)
- liver metabolism (1)
- loci (1)
- low-grade inflammation (1)
- lupin (1)
- lycopene (1)
- lymphoma (1)
- lysosomal hydrolases (1)
- lysosomal storage disorders (1)
- lysosome (1)
- mRNA degradation (1)
- macrophages (1)
- maintenance of genomic integrity (1)
- manganese (1)
- mass index (1)
- meal timing (1)
- melatonin (1)
- membrane fusion (1)
- menadione (1)
- mercuric mercury (1)
- metabolic disorders (1)
- metabolomics (1)
- methylmercury (1)
- mice lacking (1)
- microcomputed tomography (1)
- microgreen (1)
- micronutrient (1)
- micronutrients (1)
- microwave assisted digestion (1)
- middle adulthood (1)
- mitochondria (1)
- mitochondria homeostasis (1)
- mitochondrial dysfunction (1)
- mobility-mass spectrometry (1)
- model (1)
- monensin (1)
- motor neurons (1)
- mucus layer (1)
- multiple-pest infestation (1)
- muscarinic acetylcholine receptor (1)
- myalgic encephalomyelitis (1)
- myoglobin (1)
- n-acetyl-cysteine (1)
- n-oxPTH (1)
- nanogels (1)
- nanoparticles (1)
- nanotoxicology (1)
- native American ancestry (1)
- neurodegenerative diseases (1)
- neurotoxicity (1)
- neurotoxins (1)
- non-alcoholic fatty liver disease (1)
- non-alcoholic fatty liver disease (NAFLD) (1)
- nonalcoholic steatohepatthis (1)
- nut allergenic proteins (1)
- nutrient transport (1)
- nutritional characteristics (1)
- nuts (1)
- omega-3 fatty acids (1)
- ontogeny (1)
- open-field (1)
- organic compounds adsorption (1)
- organic mercury (1)
- overweight (1)
- oxidation (1)
- p53 (1)
- parchment (1)
- particle characterization (1)
- patterns (1)
- pea (1)
- peptide biomarkers (1)
- peptides markers (1)
- perfused-rat-liver (1)
- phagocytosis (1)
- phenolics (1)
- pink1 (1)
- plant volatiles (1)
- plasma measurements (1)
- poly(ADP-ribosyl)ation (1)
- polyenoic fatty acids (1)
- population-specific risk marker (1)
- post-natal (1)
- potency assessment (1)
- pre-natal (1)
- prediction (1)
- pregnancy (1)
- preterm infant (1)
- probiotics (1)
- prospective study (1)
- prostaglandin E2 (1)
- prostaglandin-f2-alpha (1)
- prostate cancer (1)
- protein (1)
- protein extraction (1)
- protein modification (1)
- protein restriction (1)
- proteinuria (1)
- provitamin A (1)
- purification (1)
- rat hepatocytes (1)
- redox state (1)
- redox-metabolites (1)
- reducing agents (1)
- relative dose response test (1)
- relative quantification (1)
- renal disease (1)
- repetitive elements (1)
- replacement (1)
- resistin (1)
- reversed-phase chromatography (1)
- risk (1)
- s-glutathionylation (1)
- saliva (1)
- sample preparation (1)
- seeds (1)
- selenite (1)
- selenium (1)
- selenoprotein P (1)
- serine palmitoyltransferase (1)
- serum (1)
- sex (1)
- size (1)
- skeletal-muscle (1)
- skin equivalents (1)
- skin penetration (1)
- sorghum (1)
- spent coffee grounds (1)
- sphingolipid de novo synthesis (1)
- sphingolipid metabolism (1)
- sphingomyelin (1)
- sphingosine kinase (1)
- stable-isotope labeling (1)
- status markers (1)
- suppress VLDL secretion (1)
- tacrolimus formulation (1)
- targeted proteomics (1)
- tetanus toxin (1)
- thermal processing of food (1)
- thermoresponsive-nanogel (1)
- thiomersal (1)
- topical (1)
- transformation products (1)
- transthyretin (1)
- tritrophic system (1)
- tryptic digestion (1)
- type 2 diabetes (1)
- ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) (1)
- valorization (1)
- variants (1)
- vegetables (1)
- veterinary drugs (1)
- vicious cycle (1)
- visfatin (1)
- vitamin A (1)
- voltage-dependent calcium channels (1)
- weight gain (1)
- weight loss (1)
- wheat cultivars (1)
- white adipose tissue (1)
- zinc binding (1)
- α-tocophero (1)
Institute
- Institut für Ernährungswissenschaft (104) (remove)
The complement fragments C3a and C5a were purified from zymosan-activated human serum by column chromatographic procedures after the bulk of the proteins had been removed by acidic polyethylene glycol precipitation. In the isolated in situ perfused rat liver C3a increased glucose and lactate output and reduced flow. Its effects were enhanced in the presence of the carboxypeptidase inhibitor DL-mercaptomethyl-3-guanidinoethylthio-propanoic acid (MERGETPA) and abolished by preincubation of the anaphylatoxin with carboxypeptidase B or with Fab fragments of an anti-C3a monoclonal antibody. The C3a effects were partially inhibited by the thromboxane antagonist BM13505. C5a had no effect. It is concluded that locally but not systemically produced C3a may play an important role in the regulation of local metabolism and hemodynamics during inflammatory processes in the liver.
In the isolated rat liver perfused in situ stimulation of the nerve bundles around the portal vein and the hepatic artery caused an increase of urate formation that was inhibited by the α1-blocker prazosine and the xanthine oxidase inhibitor allopurinol. Moreover, nerve stimulation increased glucose and lactate output and decreased perfusion flow. Infusion of noradrenaline had similar effects. Compared to nerve stimulation infusion of glucagon led to a less pronounced increase of urate formation and a twice as large increase in glucose output but a decrease in lactate release without affecting the flow rate. Insulin had no effect on any of the parameters studied.
Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a
(1993)
Human anaphylatoxin C3a increases glycogenolysis in perfused rat liver. This action is inhibited by prostanoid synthesis inhibitors and prostanoid antagonists. Because prostanoids but not anaphylatoxin C3a can increase glycogenolysis in hepatocytes, it has been proposed that prostanoid formation in nonparenchymal cells represents an important step in the C3a-dependent increase in hepatic glycogenolysis. This study shows that (a) human anaphylatoxin C3a (0.1 to 10 mug/ml) dose-dependently increased prostaglandin D2, thromboxane B, and prostaglandin F2alpha formation in rat liver macrophages (Kupffer cells); (b) the C3a-mediated increase in prostanoid formation was maximal after 2 min and showed tachyphylaxis; and (c) the C3a-elicited prostanoid formation could be inhibited specifically by preincubation of C3a with carboxypeptidase B to remove the essential C-terminal arginine or by preincubation of C3a with Fab fragments of a neutralizing monoclonal antibody. These data support the hypothesis that the C3a-dependent activation of hepatic glycogenolysis is mediated by way of a C3a-induced prostanoid production in Kupffer cells.
Prostaglandins, released from Kupffer cells, have been shown to mediate the increase in hepatic glycogenolysis by various stimuli such as zymosan, endotoxin, immune complexes, and anaphylotoxin C3a involving prostaglandin (PG) receptors coupled to phospholipase C via a G(0) protein. PGs also decreased glucagon-stimulated glycogenolysis in hepatocytes by a different signal chain involving PGE(2) receptors coupled to adenylate cyclase via a G(i) protein (EP(3) receptors). The source of the prostaglandins for this latter glucagon-antagonistic action is so far unknown. This study provides evidence that Kupffer cells may be one source: in Kupffer cells, maintained in primary culture for 72 hours, glucagon (0.1 to 10 nmol/ L) increased PGE(2), PGF(2 alpha), and PGD(2) synthesis rapidly and transiently. Maximal prostaglandin concentrations were reached after 5 minutes. Glucagon (1 nmol/L) elevated the cyclic adenosine monophosphate (cAMP) and inositol triphosphate (InsP(3)) levels in Kupffer cells about fivefold and twofold, respectively. The increase in glyco gen phosphorylase activity elicited by 1 nmol/L glucagon was about twice as large in monocultures of hepatocytes than in cocultures of hepatocytes and Kupffer cells with the same hepatocyte density. Treatment of cocultures with 500 mu mol/L acetylsalicylic acid (ASA) to irreversibly inhibit cyclooxygenase (PGH-synthase) 30 minutes before addition of glucagon abolished this difference. These data support the hypothesis that PGs produced by Kupffer cells in response to glucagon might participate in a feedback loop inhibiting glucagon-stimulated glycogenolysis in hepatocytes.